Steris STE
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Steris (STE) Business Model and Operations Summary
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Key Insights
Steris (STE) Core Market Data and Business Metrics
Latest Closing Price
$225.72Market Cap
$22.16 BillionPrice-Earnings Ratio
47.82Total Outstanding Shares
98.25 Million SharesTotal Employees
18,179Dividend
$0.57 Per Share QuarterlyIPO Date
June 2, 1992SIC Description
Orthopedic, Prosthetic & Surgical Appliances & SuppliesPrimary Exchange
New York Stock ExchangeHeadquarters
70 Sir John Rogerson's Quay, Dublin, L2, 2
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $-40.41 Million |
| Net Cash Flow From Financing Activities | $-1.54 Billion |
| Net Cash Flow, Continuing | $-32.98 Million |
| Net Cash Flow From Operating Activities, Continuing | $1.14 Billion |
| Net Cash Flow From Financing Activities, Continuing | $-1.54 Billion |
| Net Cash Flow From Investing Activities, Continuing | $362.97 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit | $171.48 Million |
| Income/Loss From Discontinued Operations Net Of Tax | $-149.00 Million |
| Selling, General, and Administrative Expenses | $1.31 Billion |
| Common Stock Dividends | $2.18 |
| Net Income/Loss | $469.00 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $1.41 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $422.37 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss Attributable To Parent | $-121.62 Million |
| Other Comprehensive Income/Loss | $-72.42 Million |
| Comprehensive Income/Loss | $422.37 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Current Liabilities | $492.04 Million |
| Equity Attributable To Noncontrolling Interest | $12.45 Million |
| Current Liabilities | $891.12 Million |
| Wages | $160.78 Million |
| Liabilities And Equity | $10.01 Billion |
| Noncurrent Liabilities | $2.69 Billion |
Historical Dividends
Current dividend: $0.57 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 28, 2025 | Mar 21, 2025 | Feb 20, 2025 | $0.57 | Quarterly |
| Oct 30, 2024 | Dec 19, 2024 | Nov 19, 2024 | $0.57 | Quarterly |
| Jul 31, 2024 | Sep 20, 2024 | Sep 5, 2024 | $0.57 | Quarterly |
| May 1, 2024 | Jun 26, 2024 | Jun 12, 2024 | $0.52 | Quarterly |
| Jan 30, 2024 | Mar 22, 2024 | Feb 23, 2024 | $0.52 | Quarterly |
| Oct 31, 2023 | Dec 21, 2023 | Nov 21, 2023 | $0.52 | Quarterly |